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Continued from page 50 be achieved by this method, and discard data items which have low completion rates anWor are thought to be inaccurate.
It is doubtful whether detailed data on staging and treatment methods can be collected reliably at central level. Hospital-based cancer registries or follow-up studies on a sample of Cancer Registry data can be used to collect additional information.
Cancer registration has a primarily statistical purpose which is aimed at prevention, or future control and treatment methods, and does not benefit the individuals with cancer who are registered. Thus cancer registration. differs from registration of births/deaths/marriages because there is no legal necessity and benefit for affected individuals and their families which is attached to registration of cancer.
Cancer registration also differs from registration of diseases such as tuberculosis, because such registers are actively used for individual case follow-up and contact tracing. In these circumstances cancer registration should impose the least burden possible on those who are required to supply information since there is no direct benefit for patients, their families or health care providers.
Hospital-based or area-based cancer registries in NSW are evolving and could become a useful source of information on survival for various cancers for different treatment protocols, since accurate data in this amount of detail can only be collected locally.
The organisation and funding requirements of a cancer registry are related to:
(a) the number of cancers occurring in the community it serves -which is a function of the age-specific incidence and age structure of the population;
(b) the intensity of treatment and number of reporting sources -which have a multiplier effect on (a); and (c) the size of the data base -which is related to the number of cancers registered per year and the length of the collection. The difficulties with cancer registration seem to increase geometrically (rather than linearly) with increasing size, unless accompanied by a high level of automation and compromises concerning data items and accuracy.
OBJECTIVES OF THE NSW CENTRAL CANCER REGISTRY

Overall objectives
To contribute to the prevention, control and treatment of cancer in the population of NSW, in particular; and human populations, in general, by the supply of timely and accurate data based on a total enumeration of cases of cancer in NSW -which meets statutory requirements and the needs of users.
Specific objectives
of the skin (but including SCC of the lip, vulva, penis and anus), and except carcinoma-in-situ.
Priority 2: Timeliness of the data.
Priority 3: Accuracy in the variables collected.
Priority 4: Dead or alive status current for each individual registered (for survival analysis).
Priority 5:
Completeness of variables which are to be collected on each case.
Priority 6:
Compatibility of the data with other State registries in Australia and internationally.
2.2
Objectives related to acquisition of data 2.2.1 Reporting and data items will be kept to a minimum. In some instances, only the first contact, death and new primary cancers will be reported from hospitals and radiotherapy departments. 
Descriptive epidemiology
Analyse and publish descriptive data concerning cancer incidence and mortality in NSW:
(a) magnitude of the health problem due to various cancers. This is measured by incidence and mortality rates.
(b) distribution of various cancers by age, sex and country of birth.
(c) survival for various cancers by age group, sex and other factors.
(d) small area differentials in incidence and mortality for various cancers. Small areas include urban/rural, health areas/regions, local government areas, postcodes or appropriate aggregations.
(e) temporal trends in incidence and mortality from various cancers, and temporal trends in survival.
(f) patterns of referral for diagnosis and treatment of various cancers (and temporal trends), and patterns of treatment for various cancers (and temporal trends). These aims will, require additional ad hoc surveys based on registered cases.
Collaboration with the Cancer Epidemiology
Research Unit and other Institutions. This consists of provision of data for:
(a) more detailed descriptive epidemiological studies related to cancer using subsamples of the Registry data base.
(b) descriptive.analytic studies of cancer incidence and mortality in relationship to other variables (ecological studies and before-and-after studies).
(c) analytic epidemiological studies using case control and cohort methodologies.
(d) case series studies by clinicians, radiotherapists, pathologists or other medical scientists.
Reports and publications
The NSW Central Cancer Registry will publish an annual report of cancer incidence in NSW and reports related to cancer epidemiology derived from routinely collected data sources. Anthrax is a zoonosis that was endemic in Europe before the introduction of an effective animal vaccine. Koch, in the late 1800s, demonstrated the bacterial aetiology of anthrax, the first disease to which a bacterial cause was ascribed.'
Richard
Human anthrax is still a problem in many regions of the wor1d,6''4" although in developed countries it is uncommon. In NSW there have been only two reported cases of human anthrax since 1982.
Anthrax is caused by the Bacillus anthracis, a sporeforming, gram-positive organism. The spores are extremely resistant to adverse environmental conditions,6 surviving high temperatures and drying, and can remain dormant but potentially infective for more than 20 years? Pathophysiologic effects in infected animals or humans are due to toxins produced by the organism?
The main reservoirs of infection are domestic herbivores such as sheep, cattle and goats. Human infection comes from direct contact with contaminated skins or carcasses, inhalation of spores from contaminated animal products such as wool fibres or bone meal, or from eating infected meat?
The index case, a 35-year-old male, initially presented to a general practitioner with a number of vesicular lesions on his hands which the patient himself suspected to be anthrax. The patient was otherwise well and was given oral penicillin. In the following 24 hours, the man became systemically unwell and was admitted to a metropolitan hospital for intravenous penicillin therapy.
The vesicular lesions developed black necrotic lesions typical of cutaneous anthrax. B. anthracis was cultured from the swabs taken by the GP. The organism was not found in the patient's blood or in the lesions.
Three days before going to the GP, the patient, with two others, had been slaughtering sheep on a property in western NSW. There was no evidence of anthrax on that property, although it was known to be present in neighbouring properties.
The carcasses were to be used as feed for animals in a Sydney wildlife park. Eight other staff members of the park had direct contact with the carcasses.
Anthrax is common among stock in NSW, but human anthrax is uncommon. It is potentially fatal, especially if accompanied by septicaemia and severe toxaemia. Cutaneous anthrax comprises 90-95 per cent of all human anthrax, and has a case fatality rate of 10-20 per cent if untreated?
For public health, it is important that all human contacts be treated appropriately, and that contaminated materials be disposed of in a manner that eliminates further human or animal exposure.
All definite contacts, and many others at the wildlife park who were not at risk, were treated with oral penicillin for at least five days. The treatment of noncontacts was unnecessary but deemed justifiable in view of the high level of anxiety, and the relatively low cost of treatment.
It is recommended that contaminated materials be incinerated or disinfected, and that infected carcasses be covered with anhydrous calcium oxide (quicklime) during deep burial? Some of the potentially contaminated materials were burnt, while others were disinfected with 5 per cent formalin solution.
The contaminated carcasses were buried, without any quicklime, at a local waste depot before involvement of the Public Health Unit. Though not the most appropriate site for disposal, it was the most accessible at the time. Fortunately, the buried carcasses are unlikely to be disturbed, since as normally is the case, the waste depot would be designated 'unhealthy building land' under the Public Health Act.
There was the potential for many more cases of human anthrax and it was fortunate that only one case was confirmed. In this case the diagnosis was confirmed by bacterial culture. If microbiological confirmation is not possible, or in epidemiological investigations, serological diagnosis is both sensitive and specific" Eradication of human anthrax depends primarily on the ability to control it in domestic animals by effective surveillance and vaccination programs. Vaccination for humans is not available in Australia, so preventive measures should be emphasised to high-risk groups.
Bin Jalaludin Research officer
Elizabeth Sullivan Acting director Western Sector Public Health Unit 
REDUCING FATAL CHILDHOOD INFECTIONS
T he importance of Haemophilus influenzae type b (Hib) as a cause of severe infections in young children is not generally appreciated by health care workers outside children's hospitals or the general public. This is probably because severe Nib disease is largely restricted to young children (at least 90 per cent of cases occur by five years of age), although there have been a number of case series reporting disease in adults,' particularly epiglottitisi' Despite the restricted age group affected, the annual mortality caused by Nib in the US has been calculated as comparable to that of epidemic poliomyehtis in the early 1950ai Universal immunisation against Nib disease has been recommended in a number of countries, including the US (since 1985) and Canada To assess the value to the Australian community of immunisation, data on the costs of Nib disease (which depends on disease incidence and sequelae) and the efficacy, costs and side-effects of the vaccine (which depends on population characteristics and vaccine type) are needed. Decisions about vaccine delivery (universal vs targeted and timing and number of doses) are also important.
EPIDEMIOLOGY OF HIB DISEASE Pattern of fib disease
The epidemiology of invasive Haemophilus disease differs markedly in different geographic areas. The most important differences are the total disease incidence, the age distribution and the proportion of epiglottitis, which are inter-related and have important implications.
The highest reported annual incidence of invasive Hcumophilus disease in the world is that in Central Australian Aboriginal children (900 per 100,000 children under five years). Epiglottitis rarely occurs in these groups, in whom most cases occur in the first six months of life, affecting up to 2 per cent of children by their first birthday. Population-based data on childhood Nib disease show a pattern of Hib disease in urban Australia which resembles that in Scandinavia most closely, with an annual incidence of 30-60 pci-100,000 for all Rib disease with a relatively high incidence of epiglottitis (13-23 per 100,000). Using a mid-range estimate of incidence (40), a minimum of 500 cases occur each year in children under five years in Australia. In a recent study of childhood Hib disease in the greater Sydney metropolitan area, 292 cases in children 0-14 years were identified between 1985 and 1987, an average of about 100 a year.' Meningitis accounted for the majority of cases (51 per cent), and epigiottitis (32 per cent), with the remainder predominantly cellulitis (6 per cent), arthritis (5 per cent) and pneumonia (4 per cent). Most studies from the US report a higher incidence for all Rib disease (60-100 per 100,000) but much less epiglottitis (2-11 per 100,000)i This difference in the incidence of epiglottitis largely explains the differences in age distribution, with 50 per cent of cases being over 24 months in Australia"7 and Finland compared to 20 per cent or fewer in the US. In general, as a higher disease incidence occurs, a lower median age of onset is noted and epigiottitis is found to be relatively less.
Risk factors for Hib disease
Case control studies in the US and Finland have identified day-care outside the home and the presence of young siblings as independent risk factors, whereas breast feeding was protective"°" The interaction of day-care attendance and age differed in two US studies, increasing indirectly with age in Atlanta' but directly with age in Colorado." The attributable risk for Rib disease from day-care was estimated to be 50 per cent in Atlanta There is evidence of genetic differences in susceptibility to Hib disease, as well as differences between strains of Hib, but race and ethnicity were not associated with an increased risk of Hib disease after correction for demographic variables in one studyi' There are differences in the findings and obvious sociodemographic differences between each area and Australia. Case-control studies are in progress in Sydney and Melbourne to evaluate the importance of these and other risk factors in Australia.
PUBLIC HEALTH IMPORTANCE OF HIB DISEASE
The magnitude of Nib as a public health problem depends on its incidence, morbidity and mortality.
Incidence
The reported incidence of Hib disease in urban Australia varies from 30 per 100,000 in Adelaide," to 60 in Victoria and the C-old Coast" and there are also differences in the pattern of disease, with Victoria having a high proportion of epiglottitis. Although some differences may relate to case ascertainment, real differences may exist between urban areas of Australia, in addition to those in rural Aboriginal children, as has been described in New Zealand'4 and the US'.
Mortality
Sudden death before hospital admission occurs in both meningitis" and epiglottitis' and thus mortality will be underestimated if only hospital records are used or if autopsies are not expertly performed. In Sydney in 1985-8 7, an average of two deaths occurred annually, all of which were due to meningitis and occurred before or soon after hospital admission. The case fatality rate may be higher for NSW as a whole, as rapid access to sophisticated medical care, such as is necessary for epiglottitis, is not available in some areas. If the case fatality rates and incidence of disease observed in Victoria' and Sydney' are projected to Australia, a minimum of 13 deaths are estimated to occur each year due to childhood Rib disease in this country.
Short-term morbidity
The short-term morbidity and costs of Nib disease primarily relate to hospitalisation. In Sydney in 1985-87, the mean number of hospital days for meningitis was 15, epiglottitis 5, arthritis 11 and other foci 5, with meningitis accounting for 71 per cent and epigiottitis 16 per cent of the 2916 bed days over this period. However, epiglottitis accounted for more than two-thirds of the 416 intensive-care bed days, whose crude cost is about three times greater than standard hospital days. Long-term morbidity The only published Australian study of post-meningitis morbidity is about 15 years old, included only 14 patients and suggested that significant morbidity was uncommon." However, preliminary follow-up data from the 138 surviving patients with meningitis in Sydney in 1985-87 indicate otherwise. Major morbidity (retardation, profound deafness, hydrocephalus) occurred in 7 per cent of children and less severe deficits (fits, motor problems, unilateral hearing loss) in a further 13 per cent. Learning deficits, behaviour problems and other "soft" neurological problems were not studied. 
HIB VACCINE EFFICACY
VACCINE SIDE-EFFECTS
There are extensive data documenting the safety of PRP vaccine in the US' A Finnish study has shown that PRP-D retains its immunogenicity when given with triple antigen and is associated with a similar incidence of side-effects to triple antigen alone2 The main concern is the induction of a transient fall in antibody levels which has been documented with both the PRP and conjugated vaccines3 Although this maybe associated with a short period of enhanced susceptibility to invasive disease, it is not a significant consideration except in the special situation of an outbreak of Hib disease (eg a day-care centre) where chemoprophylaxis rather than vaccination is indicated, at least initially.
VACCINE COSTS
Vaccine administration differs markedly between States, which can have a substantial impact on costs. However these costs are largely fixed, and as any Hib vaccine could be given within the current schedule, additional administration costs should be minimal. Two cost analyses of PRP vaccine at two years24'25 and one of PRP-D vaccine at 18 months°5 in the US concluded that immunisation was cost-effective. In Australia, the pattern of an older disease peak and greater public funding of vaccination would be expected to make the equation more favourable. The cost of prevention of Nib disease should be put in the context of other potentially vaccine-preventable diseases, such as hepatitis B and varicella, when decisions about funding priorities are made.
CONCLUSIONS
Invasive Hib disease is a common cause of serious morbidity and mortality in Australian children, with an estimated minimum of 500 cases and 13 deaths annually. Protein conjugate vaccines are among the safest. They appear to be highly immunogenic, however good-quality data on effectiveness are available only from Finland and substantial differences may exist between populations in their response to polysaccharide vaccines. One of these conjugate vaccines has recently been licensed for use at two, four and six months in the US; licensing of two such vaccines in Australia is being reviewed. For vaccination against Hib to be effective as a public health measure, it should be introduced in a co-ordinated fashion after consideration of the various competing alternatives, the most prominent of which is vaccination against hepatitis B. Detailed consideration of the costs and benefits of universal as opposed to directed immunisation and specific vaccination schedules, both timing and number of doses, in the context of Australian data is needed. New Zealand efforts and the corporate interest in goals-based planning receiving emphasis in NSW.
MEASLES (IcD9 055)
Preventing measles has been the focus of concerted The dramatic highlight of the conference was when, public health initiatives over the past three years following their noses, president Walter Holland and through health promotion and immunisation the vice-president inspected the kitchens of the campaigns. There is evidence, howevei that the conference hotel -and declared them unfit. That coverage of measles immunisation is less than day's conference banquet was organised at another optimal. Estimates of immunisation coverage during Blackpool hotel with great haste -a fine example the recent Hunter epidemic indicate that only of rapid policy formulation and implementation 85-90% of the population of NSW are immune following hard on epidemiological inquiry -and to measles. good communication!
The three-year periodicity of measles has yet to be altered by the mass immunisation program in The centre of the epidemic was the Hunter Area. Neighbouring regions, New England and North Coast, also reported higher than average rates.
In 1990 379 cases of measles were notified. The State average for measles was 6.5 cases/100,000 population. Males and females were affected equally. The preponderence of cases in under 15-year-olds highlights the importance of schools as the site In 1989/1990 71 separations from hospital due to measles were recorded in the Inpatient Statistics Collection.
The prospect of eradicating measles is still an unachievable goal. This situation requires increased compliance with notification requirements by medical practitioners, and an ability to respond to outbreaks in a timely and efficient manner. Staff of several Public Health Units have responded effectively to measles outbreaks throughout the year.
PERTUSSIS (WHOOPING COUGH) (ICD-9 033)
Pertussis cases were notified from 15 of the 16 Area Health Services and Regions. No distinctive winter pattern could be discerned from 1990 notifications, and total notifications were lower in 1990 than for 1989.
Cases are predominantly in pre-school children, but school-age children still constitute enough cases to raise concern about the place of schools in the transmission of this disease. The NH&MRC has considered the issue of pre-school pertussis booster but in the absence of proof of pertussis transmission from school into homes with unimmunised infants, it has deferred its decision.
In 1990 152 cases of pertussis were notified. The State average for pertussis was 2.6 cases/100,000 population.
In 1989/1990 510 separations from hospital due to pertussis were recorded in the Inpatient Statistics Collection.
The pertussis vaccine still has a poor public image, and is the least effective of all vaccines routinely used. The basis for lack of confidence in this vaccine must play a large role in the persistence of widespread outbreaks of disease. Please note thatthe data contained in this Bulletin are provisional and subject to change because of late reports or changes in case classification. Data are tabulated where possible by area of residence and by the disease onset date and not simply the date of notification or receipt ol such notification.
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